NCT05568121View on ClinicalTrials.gov

A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

October 9, 2022

Study Completion Date

October 27, 2022

Conditions

Healthy

Interventions

DRUG

L04RD1

1 tablet of L04RD1

DRUG

L04TD1

1 tablet of L04TD1

DRUG

L04TD1

1 tablet of L04TD1

DRUG

L04RD1

1 tablet of L04RD1

Trial Locations (1)

08756

H plus Yangji Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY